• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状 COVID-19 自然病程中病毒清除模式:与有症状非重症 COVID-19 的比较。

Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19.

机构信息

Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, 363 Dongbaekjukjeon-daero, Giheung-gu, Yongin-si, Gyeonggi-do, Republic of Korea.

Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea.

出版信息

Int J Infect Dis. 2020 Oct;99:279-285. doi: 10.1016/j.ijid.2020.07.070. Epub 2020 Aug 5.

DOI:10.1016/j.ijid.2020.07.070
PMID:32763446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403105/
Abstract

OBJECTIVES

The aim of this study was to elucidate patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) clearance in the natural course of asymptomatic coronavirus disease 2019 (COVID-19).

METHODS

Consecutive patients with non-severe COVID-19 were included retrospectively. Asymptomatic patients with a normal body temperature and no evidence of pneumonia throughout the disease course were assigned to the asymptomatic group. The reverse transcription PCR (RT-PCR) assay was repeated every two to five days after the first follow-up RT-PCR assay. Negative conversion was defined as two consecutive negative RT-PCR assay results within a 24-h interval. Rebound of the cycle threshold (Ct) value was defined as negative from the single RT-PCR assay and positive from the following assay.

RESULTS

Among a total of 396 patients identified (median age 42.5 years (interquartile range (IQR) 25.0-55.0 years), 35.6% male), 68 (17.2%) were assigned to the asymptomatic group and 328 (82.8%) to the symptomatic group. The time until negative conversion was significantly shorter in the asymptomatic group than in the symptomatic group: median 14.5 days (IQR 11.0-21.0 days) and 18.0 days (IQR 15.0-22.0 days), respectively (p = 0.001). Rebound of Ct values was observed in 78 patients (19.7%).

CONCLUSIONS

Time until negative conversion is shorter in asymptomatic COVID-19 than in symptomatic COVID-19. Rebound of Ct values is not uncommon.

摘要

目的

本研究旨在阐明无症状 2019 冠状病毒病(COVID-19)自然病程中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)清除的模式。

方法

回顾性纳入非重症 COVID-19 连续患者。无症状患者在整个疾病过程中体温正常且无肺炎证据,被分配到无症状组。首次随访 RT-PCR 检测后,每 2-5 天重复进行 RT-PCR 检测。阴性转换定义为 24 小时内连续两次 RT-PCR 检测结果均为阴性。Ct 值的反弹定义为单次 RT-PCR 检测为阴性,随后的检测为阳性。

结果

共确定 396 例患者(中位年龄 42.5 岁(四分位距 25.0-55.0 岁),35.6%为男性),68 例(17.2%)被分配到无症状组,328 例(82.8%)被分配到有症状组。无症状组的阴性转换时间明显短于有症状组:中位数分别为 14.5 天(四分位距 11.0-21.0 天)和 18.0 天(四分位距 15.0-22.0 天)(p=0.001)。78 例患者(19.7%)出现 Ct 值反弹。

结论

无症状 COVID-19 患者的阴性转换时间短于有症状 COVID-19 患者。Ct 值反弹并不少见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1110/7403105/fb1e396bad26/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1110/7403105/e613c62220ec/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1110/7403105/b4ab4a1af54e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1110/7403105/fb1e396bad26/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1110/7403105/e613c62220ec/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1110/7403105/b4ab4a1af54e/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1110/7403105/fb1e396bad26/gr3_lrg.jpg

相似文献

1
Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19.无症状 COVID-19 自然病程中病毒清除模式:与有症状非重症 COVID-19 的比较。
Int J Infect Dis. 2020 Oct;99:279-285. doi: 10.1016/j.ijid.2020.07.070. Epub 2020 Aug 5.
2
Distribution of SARS-CoV-2 PCR Cycle Threshold Values Provide Practical Insight Into Overall and Target-Specific Sensitivity Among Symptomatic Patients.SARS-CoV-2 PCR 循环阈值分布为有症状患者的整体和目标特异性灵敏度提供了实用见解。
Am J Clin Pathol. 2020 Sep 8;154(4):479-485. doi: 10.1093/ajcp/aqaa133.
3
SARS-CoV-2 and RT-PCR in asymptomatic patients: Results of a cohort of workers at El Dorado International Airport in Bogotá, 2020.无症状患者中的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与逆转录聚合酶链反应(RT-PCR):2020年波哥大埃尔多拉多国际机场一组工作人员的结果
Biomedica. 2020 Oct 30;40(Supl. 2):166-172. doi: 10.7705/biomedica.5802.
4
Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea.韩国社区治疗中心收治的无症状和轻症冠病患者的临床病程。
Emerg Infect Dis. 2020 Oct;26(10):2346-2352. doi: 10.3201/eid2610.201620. Epub 2020 Jun 22.
5
Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)?阈值循环值能否正确反映 2019 年新型冠状病毒病(COVID-19)的严重程度?
J Infect Chemother. 2021 Jan;27(1):117-119. doi: 10.1016/j.jiac.2020.09.010. Epub 2020 Sep 9.
6
Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.真正无症状的 SARS-CoV-2 感染可能很少见:仔细访谈和随访的重要性。
J Korean Med Sci. 2020 Sep 21;35(37):e333. doi: 10.3346/jkms.2020.35.e333.
7
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.癌症患者出现 COVID-19 症状,无论 RT-PCR 是否检测到 SARS-COV-2,死亡率均较高。
Eur J Cancer. 2020 Aug;135:251-259. doi: 10.1016/j.ejca.2020.05.028. Epub 2020 Jun 7.
8
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.隔离一艘游轮上的乘客后,其体内的 SARS-CoV-2 脱落和血清转化:一项病例系列研究。
Lancet Infect Dis. 2020 Sep;20(9):1051-1060. doi: 10.1016/S1473-3099(20)30364-9. Epub 2020 Jun 12.
9
A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).一种逆转录重组酶辅助扩增检测法,用于快速检测严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的 N 基因。
Virology. 2020 Oct;549:1-4. doi: 10.1016/j.virol.2020.07.006. Epub 2020 Jul 29.
10
Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients.实时荧光定量 PCR 阴性的疑似 COVID-19 患者鼻咽拭子中通过液滴数字 PCR 检测和定量 SARS-CoV-2。
PLoS One. 2020 Sep 8;15(9):e0236311. doi: 10.1371/journal.pone.0236311. eCollection 2020.

引用本文的文献

1
The Time to Negative Conversion among Adult COVID-19 Patients on Chronic Hemodialysis Admitted at the Philippine General Hospital - A Retrospective Cohort Study.菲律宾总医院收治的接受慢性血液透析的成年新冠肺炎患者的病毒转阴时间——一项回顾性队列研究
Acta Med Philipp. 2024 Mar 22;58(5):22-27. doi: 10.47895/amp.vi0.6460. eCollection 2024.
2
Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study.一项观察性队列研究表明,奈玛特韦联合利托那韦用于治疗急性 SARS-CoV-2 感染与随后的长新冠症状有关。
J Med Virol. 2024 Jan;96(1):e29333. doi: 10.1002/jmv.29333.
3
Adhatoda vasica and Tinospora cordifolia extracts ameliorate clinical and molecular markers in mild COVID-19 patients: a randomized open-label three-armed study.

本文引用的文献

1
Community Treatment Centers for Isolation of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease, South Korea.韩国的社区治疗中心,用于隔离无症状和轻症的冠状病毒疾病患者。
Emerg Infect Dis. 2020 Oct;26(10):2338-2345. doi: 10.3201/eid2610.201539. Epub 2020 Jun 22.
2
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
3
Interpreting Diagnostic Tests for SARS-CoV-2.
水蜈蚣和三叶青提取物可改善轻度 COVID-19 患者的临床和分子标志物:一项随机、开放标签的三臂研究。
Eur J Med Res. 2023 Dec 4;28(1):556. doi: 10.1186/s40001-023-01507-7.
4
Efficacy of nasal irrigation and oral rinse with sodium bicarbonate solution on virus clearance for COVID-19 patients.鼻腔冲洗和碳酸氢钠溶液漱口对清除 COVID-19 患者病毒的疗效。
Front Public Health. 2023 Mar 15;11:1145669. doi: 10.3389/fpubh.2023.1145669. eCollection 2023.
5
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19.用于对抗SARS-CoV-2的纳米材料:预防、诊断和治疗新冠肺炎的策略。
Front Bioeng Biotechnol. 2022 Nov 25;10:1052436. doi: 10.3389/fbioe.2022.1052436. eCollection 2022.
6
Risk of air and surface contamination of SARS-CoV-2 in isolation wards and its relationship with patient and environmental characteristics.隔离病房中 SARS-CoV-2 的空气和表面污染风险及其与患者和环境特征的关系。
Ecotoxicol Environ Saf. 2022 Aug;241:113740. doi: 10.1016/j.ecoenv.2022.113740. Epub 2022 Jun 6.
7
Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium.评估无症状个体在住院或手术前在比利时佛兰德斯筛选的 SARS-CoV-2 阳性率和上呼吸道病毒载量。
PLoS One. 2021 Nov 11;16(11):e0259908. doi: 10.1371/journal.pone.0259908. eCollection 2021.
8
Viral load and rebound in children with coronavirus disease 2019 during the first outbreak in Daegu city.大邱市首次疫情期间2019冠状病毒病患儿的病毒载量与病毒反弹情况
Clin Exp Pediatr. 2021 Dec;64(12):652-660. doi: 10.3345/cep.2020.02033. Epub 2021 Oct 12.
9
SARS-CoV-2 infection in UK university students: lessons from September-December 2020 and modelling insights for future student return.英国大学生中的新冠病毒感染情况:2020年9月至12月的经验教训及对未来学生返校的建模见解
R Soc Open Sci. 2021 Aug 4;8(8):210310. doi: 10.1098/rsos.210310. eCollection 2021 Aug.
10
Gargling with 7.5% Sodium Bicarbonate Solution for SARS-CoV-2 Viremia Clearance: Our Institutional Clinical Experience.用7.5%碳酸氢钠溶液含漱清除新型冠状病毒血症:我们机构的临床经验
Indian J Crit Care Med. 2021 Jul;25(7):791-794. doi: 10.5005/jp-journals-10071-23901.
解读新型冠状病毒2019(SARS-CoV-2)诊断检测结果
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.
4
Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers.26 例无症状严重急性呼吸综合征冠状病毒 2 携带者的流行病学和临床特征。
J Infect Dis. 2020 Jun 11;221(12):1940-1947. doi: 10.1093/infdis/jiaa205.
5
The relative transmissibility of asymptomatic COVID-19 infections among close contacts.无症状 COVID-19 感染者在密切接触者中的相对传染性。
Int J Infect Dis. 2020 May;94:145-147. doi: 10.1016/j.ijid.2020.04.034. Epub 2020 Apr 18.
6
Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.血清学检测有助于在中国武汉识别无症状的新冠病毒感染。
J Med Virol. 2020 Oct;92(10):1795-1796. doi: 10.1002/jmv.25904. Epub 2020 Jun 24.
7
Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster.COVID-19 无症状感染者在家庭聚集性病例中的传播。
Int J Infect Dis. 2020 May;94:133-138. doi: 10.1016/j.ijid.2020.03.042. Epub 2020 Apr 2.
8
Out-of-Hospital Cohort Treatment of Coronavirus Disease 2019 Patients with Mild Symptoms in Korea: an Experience from a Single Community Treatment Center.韩国单社区治疗中心对新冠肺炎轻症患者的院外队列治疗:一项经验研究。
J Korean Med Sci. 2020 Apr 6;35(13):e140. doi: 10.3346/jkms.2020.35.e140.
9
Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.韩国 2019 冠状病毒病(COVID-19)实验室诊断指南。
Ann Lab Med. 2020 Sep;40(5):351-360. doi: 10.3343/alm.2020.40.5.351.
10
Follow-up of asymptomatic patients with SARS-CoV-2 infection.新型冠状病毒2019感染无症状患者的随访
Clin Microbiol Infect. 2020 Jul;26(7):957-959. doi: 10.1016/j.cmi.2020.03.024. Epub 2020 Mar 28.